Scienza e Tecnologia
Proteomics Market Revenue Growth Riding On Personalized Medicine Trend: Reports and Data
- https://www.reportsanddata.com/sample-enquiry-form/3769
Following the COVID-19 outbreak in China in late 2019, the pandemic raged across the globe. There was a fevered race against time as companies and research organizations across the globe went into overdrive to develop a vaccine. The first human trial for a vaccine began on 6 March 2020 , and the pace of vaccine development could not have been feasible and as rapid as it was had it not been for a combined proteomics and genomics approach against the SARS-CoV-2.
Proteomic technologies have advanced into numerous areas of drug discovery and development as it enables a comparative assessment of normal and diseased-state tissues, expression profiling, pharmacogenomics, and identification of biomarkers. Majority of small molecule drugs and biologics act on protein targets and this has further boosted use of proteomics technologies in biomarker discovery, target identification, validation, and lead optimization, among others.
In addition, proteomics has been playing a crucial role in development of personalized medicine by enhancing detection of protein biomarkers and protein-based molecular diagnostics. Integration of nanotechnology and proteomics has further enhanced its application in personalized medicine.
https://www.reportsanddata.com/report-detail/proteomics-market
According to analysis by Reports and Data, North America is expected to account for largest revenue share in the global market over the forecast period, attributed to increasing research and development activities, advancements in drug discovery and research and biomarker identification, rising focus on personalized medicine owing to increasing incidence of chronic diseases such as cancer, and others, and presence of key players in the region.
https://www.reportsanddata.com/request-customization-form/3769
The global proteomics market is slightly fragmented with major players operating on both regional and global scale. Key companies in the market include Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker Corporation, and GE Healthcare.
Major players operating in the market are engaged in forming strategic alliances such as partnerships, collaborations, and mergers & acquisitions to cater to growing global demand and gain a robust footing in the market. Extensive R&D, regulatory approvals, and increasing product launches have further contributed to revenue growth of the market. Some key developments in the market include:
- https://www.reportsanddata.com/checkout-form/3769
The latest report on the global proteomics market published by Reports and Data offers a detailed segmentation of the market for the forecast period 2021-2028. The global proteomics market has been segmented on the basis of product, technology, application, and region:
Pharma and Healthcare Industry
Genomics Market By Deliverables (Product, Services), By Technology (Sequencing, PCR, Microarray, Nucleic Acid Extraction And Purification, Other Technologies), By Application, And By End Users, Forecasts To 2027
Bio Decontamination Market Analysis, By Product And Services (Services, Equipment, Consumables), By Type (Chamber Decontamination, Room Decontamination), By Agent, By End Use And By Region Forecasts To 2027
ELISpot and Fluorospot Assay Market Size, Share, Analysis By Product (Assay Kits, Ancillary products, Analyzers), By Application (Cancer, Diagnostics, Vaccines, Clinical Trials, Others), By End Use, By Region Forecasts To 2026
Bioburden Testing Market Size, Share & Analysis, By Test Method (Automated Detection of Growth, Staining, Autofluorescence I, Autofluorescence II, ATP-Bioluminescence, Cytometry, Others), Application, End Use, Region, Forecasts To 2026
Pharmacogenomics (PGx) Market Size, Share, Analysis By Products And Services (Kits, Assay), By Technology (Polymerase Chain Reaction (PCR), Gel Electrophoresis) By Application (Oncology, Infectious Disease), And By End User Forecasts To 2027
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
https://www.reportsanddata.com/press-release/global-proteomics-market
Logo: https://mma.prnewswire.com/media/1579615/Reports_and_Data_Logo.jpg